A summary of the key achievements between October and December 2015 is provided below:
Scale-up of integrated HIV services had reached the following number of sites:
724 static (579 within and 145 outside of health facilities) and 188 outreach HTC sites
716 (static) ART sites
617 PMTCT sites (Option B+, all included in ART sites above)
668 Pre-ART sites
652 sites with HIV-exposed child follow-up
604,854 persons were tested for HIV and received their results; 172,574 (29%) accessed HTC for the
first time; 432,280 (71%) were repeat testers and 15,096 (3%) of these received confirmatory
testing (after having tested positive in the past). This is equivalent to 63% confirmatory testing
coverage among 24,082 patients initiating ART this quarter. 32,762 (5%) clients received a positive
result for the first time.
23,692 (>99.9%) of 23,699 blood units collected were screened for (at least) HIV, hepatitis B and
137,394 (92%) of 149,627 women at ANC had their HIV status ascertained; 10,613 (8%) of these
were HIV positive. 122,523 (98%) of 125,204 women at maternity had their HIV status ascertained
9,102 (7%) of these were HIV positive.
24,082 patients started ART this quarter.
595,186 patients were alive and on ART by end of December 2015. This means that 60% of the
estimated 1 million HIV positive population was on ART. 1 Estimated ART coverage among people in
need for treatment1 was 51% (51,105 / 101,000) for children (<15 years) and 69% (540,071 /
779,000) for adults.
76% of adults and 77% of children were retained alive on ART at 12 months after initiation. Actual
retention rates are thought to be about 10% higher due to misclassification of ‘silent transfers’ as
defaulters in clinic-based survival/retention analysis. (see section 15.4)
517,346 (93%) of 583,674 patients on first line adult ART were on regimen 5A (TDF/3TC/EFV).
76%, 69%, 66% and 65% of women started under Option B+ were retained on ART at 6, 12, 24 and
36 months after initiation, respectively.
8,748 (8%) of infants discharged alive from maternity were known to be HIV exposed, 7,872 (90%)
of these received ARV prophylaxis (nevirapine). 7,131 (82%) were enrolled in exposed child followup
before age 2 months.
A total of 10,624 HIV exposed children and 5,650 pre-ART patients were enrolled for follow-up in
HIV Care Clinics (HCC) during this quarter.